Good morning, everyone, and nice to see you again. We had a smashing time this weekend and we hope your respite was equally invigorating. Now, though, the routine of meetings and deadlines has returned. In fact, we have a big day of R&D ahead of us. To prepare, we are indulging in a delightful cup of stimulation - Cinnamon Cream Swirl is our choice this time - and invite you to join us. We would also like to invite you to a webinar on May 23 about Salesforce Effectiveness (
please see here). Meanwhile, here are some tidbits to get you started. Have a great day and stay in touch...Servier Goes On Trial Over Mediator Scandal (Reuters)
FDA Panel Recommends Gilead HIV Quad Medicine (Dow Jones)
Arena And Eisai Expand Diet Pill Agreement (PharmaBiz)
Indian Panel To Meet To Prices On Hundreds Of Drugs (Economic Times)
Roche Bets On An Alzheimer's Drug (Bloomberg News)
FDA Eases Sterility Test Requirement For Biologics (InPharma Technologist)
New Zealand Drugmakers Deny Plans To Undermine Pharmac (Pharma Times)
Drugmakers Pledge To University Of Dundee Discovery Center (The Scotsman)
Marken Considers Shipping Trial Drugs To Patient Homes (Outsourcing Pharma)
Canadian Hearing For Chantix Class-Action Suit In Canada Nears (Times Colonist)
EDITOR'S NOTE: Please check this post for updates
sunrise pic thx to benimoto on flickr
2 Comments